Innovating Diabetes Healthcare with Advanced AI-Diagnostics
arterioscope is a spin-off from the Technical University of Graz and the result of a strategic lead project initiated in 2016, born from collaboration between academia, scientific partners, and industry leaders. Our patented technology is not just a product but an approach to revolutionizing the way we understand and manage diabetes.
Our Solution
arterioscope is an AI-powered software solution, tailored for Original Equipment Manufacturers (OEMs), healthcare institutions, and the pharmaceutical industry. We specialize in the integration and analysis of diverse data sources, such as ECG (Electrocardiography), PPG (Photoplethysmography), ICG (Impedance cardiography) or IPG (Impedance Plethysmography), to construct sophisticated digital twins. These digital counterparts serve as the foundation for advanced medical diagnostics, offering a new realm of precision in diabetes care.
The Heart of Innovation
At the core of arterioscope's patented technology lies an advanced AI algorithm, meticulously crafted to interpret complex signals like ECG, PPG, ICG and IPG. This algorithm is not just a piece of code; it's the key to unlocking patient-specific models that elevate the standard of medical diagnostics. By translating intricate data into actionable insights, we are redefining the approach to diabetes treatment.
Mission
Our mission is to harness cutting-edge technology in advancing medical diagnostics, empowering diabetes patients to live healthier lives.
Team:
Hermann Moser, Co-Founder & CEO / Vahid Badeli, Co-Founder & CTO / Sascha Ranftl, Co-Founder & CSO
Social Media Channels